Literature DB >> 20698883

MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor.

Li-Hua Zhu1, Tao Liu, Hua Tang, Rui-Qing Tian, Chang Su, Min Liu, Xin Li.   

Abstract

MicroRNAs are an evolutionarily conserved class of endogenous noncoding RNAs that modulate gene expression at the post-transcriptional level. Recently, microRNA-23a (miR-23a) has been found to function as a growth-promoting and antiapoptotic factor in hepatocellular carcinoma cells. Our previous study showed that miR-23a was significantly upregulated in gastric adenocarcinoma tissues. In this study, we found that miR-23a promoted the proliferative potential of gastric adenocarcinoma cell line MGC803. We also identified IL6R as a direct target gene for miR-23a using a fluorescent reporter assay. The mRNA and protein levels of IL6R were both inversely correlated with the miR-23a expression level. Our results demonstrate that miR-23a can target IL6R and promote the growth activity of gastric adenocarcinoma cells in vitro. The downregulation of IL6R by miR-23a may explain why the suppression of miR-23a can inhibit gastric cancer cell proliferation.
© 2010 The Authors Journal compilation © 2010 FEBS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20698883     DOI: 10.1111/j.1742-4658.2010.07773.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  44 in total

1.  MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches.

Authors:  Seyed Hamid Aghaee-Bakhtiari; Ehsan Arefian; Mahmood Naderi; Farshid Noorbakhsh; Vahideh Nodouzi; Mojgan Asgari; Pezhman Fard-Esfahani; Reza Mahdian; Masoud Soleimani
Journal:  Tumour Biol       Date:  2015-01-22

2.  MiR-34a inhibits oral cancer progression partially by repression of interleukin-6-receptor.

Authors:  Ting Li; Lichu Li; Dongshuang Li; Shuting Wang; Jinhu Sun
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  MicroRNA-193 pro-proliferation effects for bone mesenchymal stem cells after low-level laser irradiation treatment through inhibitor of growth family, member 5.

Authors:  Jue Wang; Weicong Huang; Yihe Wu; Jianfeng Hou; Yu Nie; Haiyong Gu; Jun Li; Shengshou Hu; Hao Zhang
Journal:  Stem Cells Dev       Date:  2012-04-20       Impact factor: 3.272

Review 4.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

5.  The contribution of the functional IL6R polymorphism rs2228145, eQTLs and other genome-wide SNPs to the heritability of plasma sIL-6R levels.

Authors:  Jenny van Dongen; Rick Jansen; Dirk Smit; Jouke-Jan Hottenga; Hamdi Mbarek; Gonneke Willemsen; Cornelis Kluft; Brenda W J Penninx; Manuel A Ferreira; Dorret I Boomsma; Eco J C de Geus
Journal:  Behav Genet       Date:  2014-05-03       Impact factor: 2.805

6.  Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.

Authors:  Gang Ma; Weijie Dai; Aiyu Sang; Xiaozhong Yang; Chengcheng Gao
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

7.  Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns.

Authors:  Amanda L Treece; Daniel L Duncan; Weihua Tang; Sandra Elmore; Douglas R Morgan; Ricardo L Dominguez; Olga Speck; Michael O Meyers; Margaret L Gulley
Journal:  Lab Invest       Date:  2016-03-07       Impact factor: 5.662

8.  Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles.

Authors:  Qing-Yong Chen; De-Min Jiao; Ya Zhu; Huizhen Hu; Jian Wang; Xiali Tang; Jun Chen; Li Yan
Journal:  Tumour Biol       Date:  2015-08-01

9.  Inducible microRNA-590-5p inhibits host antiviral response by targeting the soluble interleukin-6 (IL6) receptor.

Authors:  Yaqin Zhou; Zhangchuan Xia; Zhikui Cheng; Gang Xu; Xiaodan Yang; Shi Liu; Ying Zhu
Journal:  J Biol Chem       Date:  2018-10-05       Impact factor: 5.157

Review 10.  Clinically relevant microRNAs in ovarian cancer.

Authors:  Shu Zhang; Zhen Lu; Anna K Unruh; Cristina Ivan; Keith A Baggerly; George A Calin; Zongfang Li; Robert C Bast; Xiao-Feng Le
Journal:  Mol Cancer Res       Date:  2014-10-10       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.